TransCode Therapeutics Inc (RNAZ) Stock Price

9.26 ▲ +0.60 (+6.93%)
Open: 9.22 Vol: 0 Day's range: 9.22 - 9.26 Feb 18, 13:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
RNAZ Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 8.86▲ 8.91▲ 9.01▲ 9.41▼ 9.35▼
MA10 9.02▲ 9.28▼ 9.47▼ 9.58▼ 8.60▲
MA20 9.53▼ 9.49▼ 9.49▼ 9.88▼ 9.73▼
MA50 9.61▼ 9.63▼ 10.10▼ 8.81▲ 10.50▼
MA100 9.95▼ 9.69▼ 9.25▲ 9.92▼ 34.25▼
MA200 9.66▼ 10.03▼ 10.60▼ 9.70▼ 6,142.29▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.054▼ -0.075▼ -0.083▼ -0.150▼ 1.129▲
RSI 48.472▼ 46.946▼ 46.655▼ 49.078▼ 43.557▼
STOCH 23.404     16.210▼ 14.988▼ 37.257     53.373    
WILL %R -68.224     -70.815     -70.815     -70.557     -51.250    
CCI -11.199     -44.137     -50.485     -53.645     17.501    
Latest Filters Detected On RNAZ
MA $RNAZ Price Crossed Above MA(50) Set Alert
▲ GAP $RNAZ Open Gap Up %5 Set Alert
▲ GAP $RNAZ Open Gap Up %3 Set Alert
▲ GAP $RNAZ Open Gap Up %2 Set Alert
CDL $RNAZ Doji Candlestick Pattern Detected Set Alert
TransCode Therapeutics Inc News
TransCode Therapeutics, Inc.: TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138
Thursday, February 05, 2026 08:33 AM
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (TransCode), a clinical stage company pioneering immuno-oncology and RNA therapeutics ...
TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138
Thursday, February 05, 2026 05:04 AM
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (TransCode), a clinical stage company pioneering immuno-oncology and RNA therapeutics for the treatment of high risk and advanced cancers, in collaboration ...
TransCode's TTX-MC138 To Enter Phase 2a Trial As Part Of Quantum Leap PRE-I-SPY Platform
Friday, December 12, 2025 06:23 AM
(RTTNews) - TransCode Therapeutics, Inc. (RNAZ) and Quantum Leap Healthcare Collaborative, on Friday, announced a collaboration to evaluate TTX-MC138 in a Phase 2a dose-expansion trial. TTX-MC138, ...
RNAZ historical stock data
date open high low close volume
18/02/26 9.22 9.26 9.22 9.26 14,089
17/02/26 9.105 9.19 8.58 8.66 42,588
13/02/26 9.58 9.83 9.01 9.21 21,156
12/02/26 9.94 10.05 9.3001 9.88 16,070
11/02/26 10.10 10.6527 9.96 10.05 23,834
10/02/26 10.63 11.08 9.8401 10.52 67,638
09/02/26 8.60 10.95 8.60 10.72 87,641
06/02/26 9.89 10.08 7.9914 8.91 161,956
05/02/26 11.75 12.30 9.08 9.97 11,718,481
04/02/26 9.38 9.40 8.50 8.58 8,506
Quote Details
52wk Low:6.083
52wk High:233.24
Vol:0
Avg Vol(3m):5.2M
1Y Chng:-80.43%
1M Chng:+25.82%
Add to Watch List
More Information
Index US Composite
Market Cap. 8.45M